rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Refresh

524816 NATCO Group (B)

Natco Pharma Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
Zoom
435.65   1.05   0.24%
Volume 1,240
Prev close 434.60
Day's H/L (Rs.) 443.20 - 403.00
52wk H/L (Rs.) 505.20 - 330.00
Mkt Cap (Rs. Cr) 1,367.94
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com
Refresh

NATCOPHARM

Natco Pharma Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
Zoom
435.05   0.40   0.09%
Volume 16,521
Prev close 434.65
Day's H/L (Rs.) 443.00 - 430.00
52wk H/L (Rs.) 524.80 - 330.00
Turnover (Rs. Cr) 0.72
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Realtime news for Natco Pharma Ltd. (See all 480 news)

26 May 2013, 10:04
Natco recalls breast cancer drug 'Albupax' - 5 day(s) ago
Generic pharma stocks gain on positive outcome - 01 Apr 2013
Natco Pharma up 5% on huge volume - 01 Apr 2013
SC judgement on Novartis: Pro-people or anti-R&D - 02 Apr 2013
SC ruling on Novartis victory of humanity over commercial consideration: Bhaskar Narayana, Natco Pharma - 01 Apr 2013

Market Voices for Natco Pharma Ltd.  (See all 39 market voices)   

140 Characters
  Cancel
Expert Voices - 05 Mar 2013
#Natco-Pharma-Ltd
: Drugs would be sold at affordable prices and we would pay 7-8% royalty to Bayer. (NDTV Profit)
#money
Reply   |   Share
Rekha M - 21 Mar 2013 could see Natco above 550 soon.
#Natco-Pharma-Ltd
#money
Reply   |   Share
Angara Ramacharyulu - 2 months ago  Is it good to buy this stock at these levels for 2-3 months span for a target of 550?
Reply   |  Share
rekha m - 2 months ago  Dispute with Bayer over cancer dug in court but it is a good stock to buy and hold.
Reply   |  Share

BSE Announcements from Natco Pharma Ltd. (See all)

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 - 15 May 2013
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 - 11 Mar 2013

Company details for Natco Pharma Ltd.

Report Card

PE Ratios
21.84
EPS (Rs.)
19.95
Sales (Rs. Cr)
150.31
Face Value (Rs.)
10
Net Profit
Margin (%)
 
13.95
Last Bonus
Last Dividend(%)
40
Return on
Average Equity
 
13.29

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Mutual Funds Invested

Natco Pharma Ltd. performance snapshot

If you had invested Rs.  in Natco Pharma Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Natco Pharma Ltd. with other stocks

GlaxoSmithKline Pharmaceuticals Ltd.
2,279.50
Compare
Dr. Reddy's Laboratories Ltd.
2,051.05
Compare
Show more companies
GlaxoSmithKline Pharmaceuticals Ltd.
2,279.50
Compare
Dr. Reddy's Laboratories Ltd.
2,051.05
Compare
Cipla Ltd.
415.00
Compare
Biocon Ltd.
275.60
Compare
Cadila Healthcare Ltd.
787.50
Compare
Ipca Laboratories Ltd.
578.25
Compare
Lupin Ltd.
748.90
Compare
Divi's Laboratories Ltd.
980.30
Compare
Glenmark Pharmaceuticals Ltd.
572.00
Compare
Strides Arcolab Ltd.
885.65
Compare
Show less companies

ALL MONEYWIZ PAGES

rediff on the net© 2013 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add Natco Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Natco Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close